Business · 28/03/1994Updated: 10/15/2026 · 1 min read
Chelsea Laboratories, Inc.; Withdrawal of Approval of 26 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 26 abbreviated new drug applications held by Chelsea Laboratories, Inc. due to the company's request to withdraw approval as the drug products are no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →